Gilead Sciences (GILD) Tops Q1 EPS by 4c; maintains guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $125.87 +3.61%
EPS Growth %: -427.9%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
CRMT, REPL, ANIX, More
EPS Growth %: -427.9%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
CRMT, REPL, ANIX, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.81, $0.04 better than the analyst estimate of $1.77. Revenue for the quarter came in at $6.67 billion versus the consensus estimate of $6.78 billion.
GUIDANCE:
Gilead Sciences sees FY2025 EPS of $7.70-$8.10, versus the consensus of $7.95. Gilead Sciences sees FY2025 revenue of $28.2-28.6 billion, versus the consensus of $28.729 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- Hyperscale Data begins production of first 30 humanoid robots
- McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
